Sarepta Stock News, Researches, Clinical Trials and Articles

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Powered by Hostinger

Latest Articles

If Elevidys Works for Duchenne Muscular Dystrophy, Why Is Sarepta’s Stock Falling? What Families Need to Know Before Choosing Gene Therapy

Editorials June 12, 2026 0

Few Duchenne muscular dystrophy (DMD) treatments have generated as...

GEn1E Lifesciences and GEn-1123: A New Precision Medicine Approach for Duchenne Muscular Dystrophy (DMD)

Press Releases June 10, 2026 0

The U.S. Food and Drug Administration (FDA) has granted...

Pain Management in Duchenne Muscular Dystrophy: A Parent’s Guide to Helping Your Child Live More Comfortably

Care Guidelines June 5, 2026 0

Living with Duchenne muscular dystrophy (DMD) involves far more...

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Therapies December 26, 2024 4

A genetic condition known as Duchenne muscular dystrophy (DMD)...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 9

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 2

The duchenne muscular dystrophy treatment cost has become one...

Duchenne MD

Genetic

Care Guidelines

Health Guidelines

Sarepta Stock

Must Read

How Do I Know if My Child Has Muscular Dystrophy? Critical Symptoms You Should Never Ignore

Best Physical Therapy Strategies for Duchenne Muscular Dystrophy

Occupational Therapy in Duchenne Muscular Dystrophy: Complete Guide to DMD Rehabilitation